CTRI/2024/01/061978
Not yet recruiting
Phase 2
Therapeutic Efficacy of Multimodal Imaging-Guided Brain Network Modulation through Personalized, Multisession, High-density Transcranial Direct Current Stimulation in Drug-Resistant Focal Epilepsy: A Double-Blind Sham-Controlled Study - NI
Dr. Suriya Prakash Muthukrishnan0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Dr. Suriya Prakash Muthukrishnan
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Proven focal onset seizures
- •H/o for at least 2 years refractory to antiepileptic drugs
Exclusion Criteria
- •Pseudoseizures
- •Progressive brain disorders or systemic diseases other than epilepsy
- •Genetic aetiology
- •Patients with implants
- •Change of AEDs during the course of the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Phase 2a open label study of Fovista¿ (anti-PDGF agent) administered in combination with anti-VEGF therapy in subjects previously treated or treatment-naive.Subfoveal choroidal neovascularization secondary to Age-Related Macular Degeneration (AMD)MedDRA version: 20.0Level: PTClassification code 10071129Term: Neovascular age-related macular degenerationSystem Organ Class: 10015919 - Eye disordersMedDRA version: 20.1Level: LLTClassification code 10067791Term: Wet macular degenerationSystem Organ Class: 10015919 - Eye disordersTherapeutic area: Diseases [C] - Eye Diseases [C11]EUCTR2015-000519-42-ITIVERIC bio, Inc.32
Active, not recruiting
Phase 1
Role of imaging in the evaluation of anatomic alterations in neovascular Age-Related Macular Degeneration (AMD) subjects: 18 month study of Fovista® (anti-PDGF therapy) administered in combination with anti-VEGF therapySubfoveal choroidal neovascularization secondary to Age-Related Macular Degeneration (AMD)MedDRA version: 18.0 Level: PT Classification code 10071129 Term: Neovascular age-related macular degeneration System Organ Class: 10015919 - Eye disordersMedDRA version: 18.0 Level: LLT Classification code 10067791 Term: Wet macular degeneration System Organ Class: 10015919 - Eye disordersTherapeutic area: Diseases [C] - Eye Diseases [C11]EUCTR2015-000519-42-FROPHTHOTECH CORPORATIO32
Recruiting
Not Applicable
The multimodarity imaging assesssment using MRI and US related to the associaton between the skeletal muscle and the liver.JPRN-UMIN000009557niversity of Tsukuba70
Active, not recruiting
Phase 1
Prospektive Evaluation von Multimodality Imaging Verfahren (PET - CT - MRT - US - Bildfusion) bei malignen Tumoren der Kopf-Hals-RegioPatients with malignant Head and Neck Tumors - Diagnostic Imaging StudyMedDRA version: 9.1Level: LLTClassification code 10049516Term: Malignant tumorEUCTR2007-004393-81-ATMedizinische Universität Innsbruck - Universitätsklinik für Radiodiagnostik (Radiologie I)270
Completed
Not Applicable
Effectiveness and mechanisms of a multimodal treatment for low back pain: a pragmatic matched cohort studyM54DorsalgiaDRKS00030389Bundesinstitut für Sportwissenschaft316